CoChat

Randomized, Placebo-Controlled Trial of Fluoxetine for Acute Treatment of Minor Depressive Disorder

Judd, Lewis L., Rapaport, Mark Hyman, Yonkers, Kimberly A., Rush, A. John, Frank, Ellen, Thase, Michael E., Kupfer, David J., Plewes, John M., Schettler, Pamela J., Tollefson, Gary · 2004 · American Journal of Psychiatry
Cited by 82

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Minor depressive disorder is both common and associated with significant psychosocial impairment. This study examined antidepressant treatment efficacy in a large group of patients with minor depressive disorder. METHOD: One hundred sixty-two patients with minor depressive disorder were randomly assigned to receive fluoxetine or placebo in a 12-week, double-blind study; 73% (59 of 81) of the patients in each treatment group completed the study. Patients were evaluated weekly with standard depression rating instruments and measures of psychosocial impairment. Hypotheses were tested by last-observation-carried-forward analysis of variance (ANOVA) and confirmed by mixed (random-effects) regression analysis. RESULTS: At baseline, minor depressive disorder patients were mildly to moderately depressed, with a corresponding degree of functional impairment. Over 12 weeks of treatment, both ANOVA and mixed regression showed fluoxetine to be superior to placebo as indicated by significantly greater improvement of fluoxetine-treated patients in scores on the 30-item clinician-rated Inventory of Depressive Symptomatology, the 17-item and 21-item Hamilton Depression Rating Scale, the Beck Depression Inventory, and the Clinical Global Impression severity scale. Improvement in Global Assessment of Functioning Scale score was significantly greater for the fluoxetine group in mixed regression analysis only. Patients in both treatment groups reported a similar number and severity of adverse events during the 12-week treatment period. CONCLUSIONS: Clinicians frequently encounter minor depressive disorder either as a prodromal or residual phase of illness in major depressive disorder or as de novo minor depressive disorder episodes. Fluoxetine is significantly superior to placebo in reducing minor depressive disorder symptoms within a 12-week period. Improvement in psychosocial function with fluoxetine may take longer than 12 weeks.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/ajp.161.10.1864

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 21

  1. Broadhead WE, Blazer DG, George LK, Tse CK: Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA 1990; 264:2524–2528 · DOI
  2. Skodol AE, Schwartz S, Dohrenwend BP, Levav I, Shrout PE: Minor depression in a cohort of young adults in Israel. Arch Gen Psychiatry 1994; 51:532–551 · DOI · Paper page
  3. Judd LL, Akiskal HS, Zeller PJ, Paulus MP, Leon AC, Maser JD, Endicott J, Coryell W, Kunovac JL, Mueller TI, Rice JP, Keller MB: Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry 2000; 37:373–380 · DOI · Paper page
  4. Rapaport MH, Judd LL, Schettler PJ, Yonkers KA, Thase ME, Kupfer DJ, Frank E, Plewes JM, Tollefson GD, Rush AJ: A descriptive analysis of minor depression. Am J Psychiatry 2002; 159:637–643 · DOI · Paper page
  5. Judd LL: Pleomorphic expressions of unipolar depressive disease: summary of the 1996 CINP President’s Workshop. J Affect Disord 1997; 45:109–116 · DOI
  6. Kendler KS, Gardner CO Jr: Boundaries of major depression: an evaluation of DSM-IV criteria. Am J Psychiatry 1998; 155:172–177 · DOI · Paper page
  7. Judd LL, Akiskal HS: Delineating the longitudinal structure of depressive illness: beyond clinical subtypes and duration thresholds. Pharmacopsychiatry 2000; 33:3–7 · DOI · Paper page
  8. Miranda J, Muñoz R: Intervention for minor depression in primary care patients. Psychosom Med 1994; 56:136–142 · DOI · Paper page
  9. Lynch DJ, Tamburrino MB, Nagel R: Telephone counseling for patients with minor depression: preliminary findings in a family practice setting. J Fam Pract 1997; 44:293–298
  10. Stewart JW, Quitkin FM, Liebowitz ME, McGrath PJ, Harrison WM, Klein DF: Efficacy of desimipramine in depressed outpatients. Arch Gen Psychiatry 1983; 40:202–207 · DOI · Paper page
  11. Paykel ES, Freeling P, Hollyman JA: Are tricyclic antidepressants useful for mild depression? a placebo controlled trial. Pharmacopsychiatry 1988; 21:15–18 · DOI · Paper page
  12. Szegedi A, Wetzel H, Angersbach D, Phillip M, Benkert O: Response to treatment in minor and major depression: results of a double-blind comparative study with paroxetine and maprotiline. J Affect Disord 1997; 45:167–178 · DOI
  13. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56–62 · DOI · Paper page
  14. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561–571 · DOI · Paper page
  15. Ware JE Jr, Sherbourne CD: The MOS 36-Item Short-Form Health Survey (SF-36), I: conceptual framework and item selection. Med Care 1992; 30:473–483 · DOI · Paper page
  16. Robins LN, Helzer JE, Croughan J, Ratcliff KS: The National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics, and validity. Arch Gen Psychiatry 1981; 38:381–389 · DOI · Paper page
  17. Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959; 32:50–55 · DOI · Paper page
  18. Derogatis LR, Lipman RS, Covi L: SCL-90: an outpatient psychiatric rating scale—preliminary report. Psychopharmacol Bull 1973; 9:13–28
  19. Andreasen NC, Endicott J, Spitzer RL, Winokur G: The family history method using diagnostic criteria: reliability and validity. Arch Gen Psychiatry 1977; 34:1229–1235 · DOI · Paper page
  20. Hedeker D, Gibbons RD: MIXREG: a computer program for mixed-effects regression analysis with autocorrelated errors. Comput Methods Programs Biomed 1996; 49:229–252 · DOI · Paper page
  21. Mintz J, Mintz LI, Arruda MJ, Hwang SS: Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 1992; 49:761–768 · DOI · Paper page

Cited by

See all 82

Metadata

Authors
Judd, L. L., Rapaport, M. H., Yonkers, K. A., Rush, A. J., Frank, E., Thase, M. E., Kupfer, D. J., Plewes, J. M., Schettler, P. J., & Tollefson, G.
Venue
American Journal of Psychiatry
Published
2004-10-01
Volume
161
Issue
10
Pages
1864-1871
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2125006286
Cited by
82
References
8
FWCI
4.89
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized, Placebo-Controlled Trial of Fluoxetine for Acute Treatment of Minor Depressive Disorder. https://app.cochat.ai/papers/10.1176/ajp.161.10.1864
The paper
Judd, L. L., Rapaport, M. H., Yonkers, K. A., Rush, A. J., Frank, E., Thase, M. E., Kupfer, D. J., Plewes, J. M., Schettler, P. J., & Tollefson, G. (2004). Randomized, Placebo-Controlled Trial of Fluoxetine for Acute Treatment of Minor Depressive Disorder. American Journal of Psychiatry. https://doi.org/10.1176/ajp.161.10.1864

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.